Skip to main content
Log in

Serum and Synovial Vancomycin Concentrations in Patients with Prosthetic Joint Infection after Intra-articular Infusion

  • Original Research Article
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

Background and Objectives

Vancomycin is one of the most commonly used antibiotics for intra-articular (IA) infusion in the treatment of prosthetic joint infection (PJI). This study aimed to preliminarily investigate the serum and synovial vancomycin concentrations in patients with PJI after IA infusion.

Methods

In total, 16 patients who developed PJI were enrolled in this study; 14 of the patients were treated with IA infusion of vancomycin postoperatively, while the other 2 patients received intravenous (IV) infusion of vancomycin alone. Chemiluminescent immunoassay assay (CLIA) and high-performance liquid chromatography (HPLC) were used to determine the serum and synovial vancomycin concentrations, respectively.

Results

Administration of vancomycin 0.5 g once daily (qd) IA maintained a high vancomycin trough concentration in synovial fluid before the next IA dose, regardless of whether it was given in combination with IV administration. The combination vancomycin 0.5 g qd IA + vancomycin 1 g every 12 h (q12h) IV yielded relatively good trough concentrations of vancomycin in both serum and synovial fluid. The mean trough serum vancomycin concentration of patients who used vancomycin 1 g q12h IV therapy was above 10 μg/mL; however, no vancomycin was detected in their synovial fluid.

Conclusions

The rational use of IA vancomycin infusion may help to achieve effective therapeutic concentrations of vancomycin in the serum and synovial fluid of patients with PJI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1–25.

    Article  Google Scholar 

  2. Ariza J, Cobo J, Baraia-Etxaburu J, Benito N, Bori G, Cabo J, et al. Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enferm Infecc Microbiol Clin. 2017;35(3):189–95.

    Article  Google Scholar 

  3. Kalson NS, Mathews JA, Alvand A, Morgan-Jones R, Jenkins N, Phillips JRA, et al. Investigation and management of prosthetic joint infection in knee replacement: a BASK Surgical Practice Guideline. Knee. 2020;27:1857–65.

    Article  CAS  Google Scholar 

  4. Taha M, Abdelbary H, Ross FP, Carli AV. New innovations in the treatment of PJI and biofilms—clinical and preclinical topics. Curr Rev Musculoskelet Med. 2018;11(3):380–8.

  5. Shoji MM, Chen AF. Biofilms in periprosthetic joint infections: a review of diagnostic modalities, current treatments, and future directions. J Knee Surg. 2020;33(2):119–31.

    Article  Google Scholar 

  6. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771–6.

    Article  CAS  Google Scholar 

  7. Argenson JN, Arndt M, Babis G, Battenberg A, Budhiparama N, Catani F, et al. Hip and knee section, treatment, debridement and retention of implant: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019;34(S2):S399–419.

  8. Davenport K, Traina S, Perry C. Treatment of acutely infected arthroplasty with local antibiotics. J Arthroplasty. 1991;6(2):179–83.

    Article  CAS  Google Scholar 

  9. Perry CR, Pearson RL. Local antibiotic delivery in the treatment of bone and joint infections. Clin Orthop Relat Res. 1991;263:215–26.

    Google Scholar 

  10. Perry CR, Hulsey RE, Mann FA, Miller GA, Pearson RL. Treatment of acutely infected arthroplasties with incision, drainage, and local antibiotics delivered via an implantable pump. Clin Orthop Relat Res. 1992;281:216–23.

    Google Scholar 

  11. Tsumura H, Ikeda S, Ono T, Itonaga I, Taira H, Torisu T. Synovectomy, debridement, and continuous irrigation for infected total knee arthroplasty. Int Orthop. 2005;29(2):113–6.

    Article  Google Scholar 

  12. Fukagawa S, Matsuda S, Miura H, Okazaki K, Tashiro Y, Iwamoto Y. High-dose antibiotic infusion for infected knee prosthesis without implant removal. J Orthop Sci. 2010;15(4):470–6.

    Article  Google Scholar 

  13. Antony SJ, Westbrook RS, Jackson JS, Heydemann JS, Nelson JL. Efficacy of single-stage revision with aggressive debridement using intra-articular antibiotics in the treatment of infected joint prosthesis. Infect Dis (Auckl). 2015;8:17–23.

    Article  Google Scholar 

  14. He R, Yang L, Guo L, Chen H, Zhang Y, Jiang DM. Management of acute hematogenous infection following total knee arthroplasty: a case series of 11 patients. Orthop Surg. 2016;8(4):475–82.

    Article  Google Scholar 

  15. Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res. 2011;469(1):26–33.

    Article  Google Scholar 

  16. Whiteside LA, Nayfeh TA, LaZear R, Roy ME. Reinfected revised TKA resolves with an aggressive protocol and antibiotic infusion. Clin Orthop Relat Res. 2012;470(1):236–43.

    Article  Google Scholar 

  17. Whiteside LA, Roy ME. One-stage revision with catheter infusion of intraarticular antibiotics successfully treats infected THA. Clin Orthop Relat Res. 2017;475(2):419–29.

    Article  Google Scholar 

  18. Nayfeh T, Whiteside LA, Hirsch M. Direct exchange treatment of septic total joint arthroplasty with intra-articular infusion of antibiotics: technique and early results. Orthopedics. 2004;27(9):987–8.

    Article  Google Scholar 

  19. Whiteside LA. Direct intra-articular antibiotic infusion for resistant organisms in the treatment of infection in joint arthroplasty. Semin Arthroplasty. 2011;22(3):185–8.

    Article  Google Scholar 

  20. Roy ME, Peppers MP, Whiteside LA, Lazear RM. Vancomycin concentration in synovial fluid: direct injection into the knee vs. intravenous infusion. J Arthroplasty. 2014;29(3):564–8.

    Article  Google Scholar 

  21. Ji B, Zhang X, Xu B, Guo W, Mu W, Cao L. Single-stage revision for chronic fungal periprosthetic joint infection: an average of 5 years of follow-up. J Arthroplasty. 2017;32(8):2523–30.

    Article  Google Scholar 

  22. Ji B, Li G, Zhang X, Wang Y, Mu W, Cao L. Effective treatment of single-stage revision using intra-articular antibiotic infusion for culture-negative prosthetic joint infection. Bone Joint J. 2020;102-B(3):336–44.

    Article  Google Scholar 

  23. Mu W, Xu B, Guo W, Ji B, Wahafu T, Cao L. Outcome of irrigation and debridement with topical antibiotics delivery for the management of periprosthetic joint infection occurring within 3 months since the primary total joint arthroplasty. J Arthroplasty. 2021;36(5):1765–71.

    Article  Google Scholar 

  24. Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006;42(Suppl 1):S35–9.

    Article  CAS  Google Scholar 

  25. Elkhodairy KA, Afifi SA, Zakaria AS. A promising approach to provide appropriate colon target drug delivery systems of vancomycin HCL: pharmaceutical and microbiological studies. Biomed Res Int. 2014;2014:182197.

    PubMed  PubMed Central  Google Scholar 

  26. Ye ZK, Chen YL, Chen K, Zhang XL, Du GH, He B, et al. Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. J Antimicrob Chemother. 2016;71(11):3020–5.

  27. He N, Su S, Ye Z, Du G, He B, Li D, et al. Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. Clin Infect Dis. 2020;71:S363–71.

  28. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469(11):2992–4.

    Article  Google Scholar 

  29. He JW, Wang Y, Ji BC, Gao HJ, Yang JH. Determination of vancomycin concentration in synovial fluid of patients with prosthetic joint infection by HPLC. Chin J Mod Appl Pharm. 2019;36(23):2949–52.

    Google Scholar 

  30. Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835–64.

    Article  Google Scholar 

  31. Metsemakers WJ, Fragomen AT, Moriarty TF, Morgenstern M, Egol KA, Zalavras C, et al. Evidence-based recommendations for local antimicrobial strategies and dead space management in fracture-related infection. J Orthop Trauma. 2020;34(1):18–29.

    Article  Google Scholar 

  32. Xu H, Yang J, Xie J, Huang Z, Huang Q, Cao G, et al. Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty. Bone Joint Res. 2020;9(11):778–88.

    Article  Google Scholar 

  33. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res. 2007;462:200–6.

    Article  Google Scholar 

  34. Chu S, Chen N, Dang ABC, Kuo AC, Dang ABC. The effects of topical vancomycin on mesenchymal stem cells: more may not be better. Int J Spine Surg. 2017;11(2):12.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian-Hua Yang.

Ethics declarations

Funding

No sources of funding were used for this study.

Conflicts of interest

The authors declare that they have no conflict of interest in relation to this study.

Ethical approval

All procedures performed in the studies were in accordance with the 1964 Helsinki Declaration and its later amendments and national institutional research committees. This study was reviewed and approved by the Institutional Review Board of the First Affiliated Hospital of Xinjiang Medical University, and has the approval number 20190531-07.

Consent to participate

Written informed consent was obtained from all participants included in this study.

Consent for publication

Not applicable.

Availability of data and materials

Data and materials supporting the findings of this study are available within the paper and its supplementary data files.

Code availability

Analysis code is available upon request from the authors.

Authors’ contributions

Jia-Wei He: data curation, formal analysis, investigation, methodology, software, writing. Jing Wang: data curation, formal analysis, investigation, methodology, software, writing. Li Cao: conceptualization, project administration, supervision. Xiao-Gang Zhang: data curation, formal analysis, investigation, resources. Guo-Qing Li: data curation, formal analysis, investigation, resources. Bo-Yong Xu: data curation, formal analysis, investigation, resources. Bao-Chao Ji: data curation, formal analysis, investigation, resources, methodology. Si-Ya Ge: data curation, formal analysis, investigation. Jian-Hua Yang: conceptualization, project administration, supervision.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, JW., Wang, J., Cao, L. et al. Serum and Synovial Vancomycin Concentrations in Patients with Prosthetic Joint Infection after Intra-articular Infusion. Eur J Drug Metab Pharmacokinet 46, 637–643 (2021). https://doi.org/10.1007/s13318-021-00705-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-021-00705-0

Navigation